OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
237880$12750.0059

Clio Cosmetics Co Ltd

Personal ProductsVerified

Clio Cosmetics Co Ltd maintains a strong liquidity position, with a current ratio of 4.38 and cash and equivalents of KRW 99.5 billion, representing 33.2% of total assets. The company's price-to-book ratio of 0.92 and price-to-tangible-book ratio of 0.92 suggest a market valuation that is in line with tangible asset value. The debt-to-equity ratio of 0.01 indicates a conservative capital structure with minimal leverage. Profitability metrics show a return on equity (ROE) of 5.58% and a return on assets (ROA) of 4.53%, which are below the industry median for Personal Products. The company's gross margin of 49.0% (calculated from gross profit of KRW 161.4 billion on revenue of KRW 328.9 billion) is in line with industry norms, but operating margin of 4.53% (KRW 14.9 billion on revenue of KRW 328.9 billion) suggests room for improvement in cost control. The company's revenue is concentrated in cosmetics and related products, with no disclosed segment breakdown. Geographically, the company operates in domestic and overseas markets, though revenue concentration by region is not specified in the input data. This lack of geographic diversification could pose a concentration risk if regional demand fluctuates. Looking ahead, the company is projected to grow revenue by 10.0% in the current fiscal year and 8.0% in the next fiscal year, based on analyst estimates. Free cash flow of KRW 8.1 billion and operating cash flow of KRW 13.2 billion support reinvestment and shareholder returns, though capital expenditures of KRW 772 million suggest modest reinvestment in operations. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high cash reserves reduce financial distress risk. However, the absence of disclosed dilution sources does not preclude future equity issuance, particularly if capital needs increase. Recent events include analyst price targets ranging from KRW 12,000 to KRW 19,000, with a mean of KRW 16,000 and a median of KRW 17,000. The mean recommendation of 2.67 (on a 1-5 scale) suggests a cautiously positive outlook, with one strong-buy and one hold rating.

30-day price · 237880+1120.00 (+9.6%)
Low$10810.00High$14000.00Close$12840.00As of12 May, 00:00 UTC
Profile
CompanyClio Cosmetics Co Ltd
Ticker237880.KQ
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Clio Cosmetics Co Ltd is a Korea-based company primarily engaged in the manufacture and distribution of cosmetics and related products, including point makeup, base makeup, and skin care basic products, with sales in domestic and overseas markets.

Classification. Clio Cosmetics Co Ltd is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry, with a confidence level of 0.92.

Clio Cosmetics Co Ltd maintains a strong liquidity position, with a current ratio of 4.38 and cash and equivalents of KRW 99.5 billion, representing 33.2% of total assets. The company's price-to-book ratio of 0.92 and price-to-tangible-book ratio of 0.92 suggest a market valuation that is in line with tangible asset value. The debt-to-equity ratio of 0.01 indicates a conservative capital structure with minimal leverage. Profitability metrics show a return on equity (ROE) of 5.58% and a return on assets (ROA) of 4.53%, which are below the industry median for Personal Products. The company's gross margin of 49.0% (calculated from gross profit of KRW 161.4 billion on revenue of KRW 328.9 billion) is in line with industry norms, but operating margin of 4.53% (KRW 14.9 billion on revenue of KRW 328.9 billion) suggests room for improvement in cost control. The company's revenue is concentrated in cosmetics and related products, with no disclosed segment breakdown. Geographically, the company operates in domestic and overseas markets, though revenue concentration by region is not specified in the input data. This lack of geographic diversification could pose a concentration risk if regional demand fluctuates. Looking ahead, the company is projected to grow revenue by 10.0% in the current fiscal year and 8.0% in the next fiscal year, based on analyst estimates. Free cash flow of KRW 8.1 billion and operating cash flow of KRW 13.2 billion support reinvestment and shareholder returns, though capital expenditures of KRW 772 million suggest modest reinvestment in operations. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high cash reserves reduce financial distress risk. However, the absence of disclosed dilution sources does not preclude future equity issuance, particularly if capital needs increase. Recent events include analyst price targets ranging from KRW 12,000 to KRW 19,000, with a mean of KRW 16,000 and a median of KRW 17,000. The mean recommendation of 2.67 (on a 1-5 scale) suggests a cautiously positive outlook, with one strong-buy and one hold rating.
Key takeaways
  • Clio Cosmetics Co Ltd has a conservative capital structure with a debt-to-equity ratio of 0.01 and strong liquidity.
  • The company's ROE of 5.58% and ROA of 4.53% are below industry medians, indicating room for improvement in asset utilization and profitability.
  • Analysts project 10.0% revenue growth in the current fiscal year and 8.0% in the next, supported by KRW 8.1 billion in free cash flow.
  • The company's geographic exposure is not fully disclosed, which could pose a concentration risk if regional demand fluctuates.
  • Analyst price targets suggest a cautiously positive outlook, with a mean of KRW 16,000 and a median of KRW 17,000.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$328.90B
Gross profit$161.36B
Operating income$14.90B
Net income$13.56B
R&D
SG&A
D&A
SBC
Operating cash flow$13.25B
CapEx-$771.7M
Free cash flow$8.14B
Total assets$299.25B
Total liabilities$56.29B
Total equity$242.97B
Cash & equivalents$99.48B
Long-term debt$2.00B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$328.90B$14.90B$13.56B$8.14B
FY-1$351.37B$24.41B$27.86B$21.99B
FY-2$330.58B$29.81B$27.70B$25.46B
FY-3$272.46B$16.31B$10.13B-$18.94B
FY-4$232.74B$9.96B$9.27B$9.50B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$299.25B$242.97B$99.48B
FY-1$295.43B$234.68B$110.97B
FY-2$279.57B$213.78B$41.67B
FY-3$243.89B$190.38B$44.12B
FY-4$234.23B$167.41B$26.19B
PeriodOCFCapExFCFSBC
FY0$13.25B-$771.7M$8.14B
FY-1$17.31B-$718.8M$21.99B
FY-2$35.73B-$869.2M$25.46B
FY-3$28.20B-$29.63B-$18.94B
FY-4$51.95B-$3.65B$9.50B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$80.62B$7.05B$3.26B$3.67B
FQ-1$83.82B$4.72B$5.53B$5.94B
FQ-2$82.13B$3.52B$2.04B$2.51B
FQ-3$82.34B$1.15B$2.74B$3.03B
FQ-4$78.25B$109.9M$2.38B$2.62B
FQ-5$87.56B$6.41B$6.12B$6.60B
FQ-6$92.58B$9.58B$9.21B$9.47B
FQ-7$92.98B$8.51B$10.16B$10.31B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$299.25B$242.97B$99.48B
FQ-1$305.26B$239.34B$117.01B
FQ-2$299.88B$234.05B$116.58B
FQ-3$317.42B$230.91B$133.04B
FQ-4$295.43B$234.68B$110.97B
FQ-5$305.43B$232.89B$104.69B
FQ-6$297.14B$226.16B$99.12B
FQ-7$302.87B$217.29B$54.26B
PeriodOCFCapExFCFSBC
FQ0$13.25B-$771.7M$3.67B
FQ-1$9.68B-$657.1M$5.94B
FQ-2$9.31B-$433.8M$2.51B
FQ-3$17.02B-$311.8M$3.03B
FQ-4$17.31B-$718.8M$2.62B
FQ-5$22.29B-$405.7M$6.60B
FQ-6$10.04B-$337.7M$9.47B
FQ-7$17.84B-$207.0M$10.31B
Valuation
Market price$12750.00
Market cap$223.44B
Enterprise value$125.96B
P/E16.5
Reported non-GAAP P/E
EV/Revenue0.4
EV/Op income8.4
EV/OCF9.5
P/B0.9
P/Tangible book0.9
Tangible book$242.97B
Net cash$97.48B
Current ratio4.4
Debt/Equity0.0
ROA4.5%
ROE5.6%
Cash conversion98.0%
CapEx/Revenue-0.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric237880Activity
Op margin4.5%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin4.1%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin49.1%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-0.2%-2.3% medp25 -4.4% · p75 -1.1%top quartile
Debt / equity1.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Mean price target16,000.00 KRW
Median price target17,000.00 KRW
High price target19,000.00 KRW
Low price target12,000.00 KRW
Mean recommendation2.67 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count1.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate1,085.50 KRW
Last actual EPS755.00 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:39 UTC#2ee3d404
Market quoteclose KRW 12750.00 · shares 0.02B diluted
no public URL
2026-05-13 00:39 UTC#87ceede1
Source: analysis-pipeline (hybrid)Generated: 2026-05-13 00:41 UTCJob: 7ba07f27